How to Investigate Unexpected CCIT Test Failures?

Unexpected container closure integrity testing (CCIT) failures should be investigated through a documented process that checks sample condition, instrument status, fixture sealing, test parameters, positive and negative controls, and recent process changes. A failed result should not be dismissed as a false rejection simply because the package looks acceptable. Zholion’s pharmaceutical leak detection equipment includes testing technologies for different pharmaceutical packaging formats, and the correct investigation begins by confirming whether the test system and method performed as intended.

For quality assurance teams, an unexpected failure raises two separate questions: does the package have an integrity defect, and was the test result generated under valid conditions? These questions should be evaluated independently before deciding whether to reject a sample, investigate a batch, or take corrective action.

 

1. Preserve the Original Failure Evidence

The first step is to preserve the initial result and all available supporting data. Repeated testing without documenting the original failure can obscure the sequence of events and weaken the investigation.

Record:

• Sample identification and batch information.

• Package type, closure configuration, and component lots.

• Date, time, operator, and instrument identification.

• Test method, recipe version, and actual parameters.

• Raw readings, test curves, alarms, and error messages.

• Fixture identification and maintenance status.

• Any deviation from the approved procedure.

If the instrument provides pressure or vacuum curves, preserve them where available. A curve may help distinguish a sudden abnormal event from a gradual pressure change or an unstable measurement.

 

2. Inspect the Failed Package

A visual inspection can identify obvious damage, but it cannot establish that a package is leak-tight. Some defects may be hidden in the closure interface or may be smaller than the visual inspection method can reliably detect.

Check for cracks, chips, stopper displacement, cap damage, incomplete sealing, deformation, or evidence of impact. For prefilled syringes, examine the relevant closure components and their positions. For flexible packages, inspect the seal area and possible folds or channels.

Handle the package according to the applicable procedure. Do not modify or dismantle a sample before preserving the evidence needed for the investigation.

If the same sample fails repeatedly under valid test conditions, consider the possibility of a genuine defect and assess whether related units may be affected.

 

3. Verify the Instrument and Fixture

An unexpected failure may originate from the test setup rather than the package. This possibility is particularly important for methods that rely on a controlled pressure or vacuum environment.

Review the instrument's calibration status, maintenance history, alarms, and reference-check results. Confirm that the fixture is correctly installed and suitable for the tested package.

Inspect the sealing surfaces, gaskets, clamps, adapters, and contact points. Residue, wear, misalignment, or inconsistent clamping can interfere with the test.

Where appropriate, run the approved system check or reference test before testing additional samples. If the control result is outside its acceptance criteria, stop and investigate the test system rather than continuing routine testing.

Zholion provides optional CCIT chambers and fixtures for different package configurations. The chamber or fixture should be matched to the package geometry and test method, then maintained according to the approved procedure.

 

4. Confirm the Test Parameters

Review the actual test parameters against the approved method. Important settings may include pressure or vacuum level, stabilization time, measurement duration, clamping sequence, and the acceptance threshold.

Do not assume that the correct recipe was used simply because its name appeared on the instrument screen. Verify the recipe version, user activity where available, and any recent configuration changes.

If a parameter was changed, determine who authorized the change, w

hy it was made, and whether the method remains valid. An undocumented adjustment can affect the interpretation of both the failed result and earlier results.

5. Check Positive and Negative Controls

Controls help establish whether a test method is behaving as expected. A suitable negative control represents a package expected to pass, while a positive control contains a defined defect or leak condition appropriate to the test method.

The controls must be suitable for the package type, measurement principle, and intended detection capability. Their use and acceptance criteria should be established in the validated procedure.

If a negative control fails unexpectedly, investigate possible system leakage, contamination, incorrect setup, or an unsuitable control sample. If a positive control does not produce the expected response, the method may not be demonstrating its intended detection capability.

Neither control should be used as a substitute for investigating the original failed package. Zholion’s CCIT positive controls are relevant to method verification and validation planning when selected for the specific application.

 

6. Review Recent Manufacturing and Handling Changes

A genuine package failure may be associated with a change in the packaging process or component supply.

Review recent changes involving:

• Stopper, cap, seal, or container suppliers.

• Component dimensions or material formulation.

• Capping or sealing machine settings.

• Assembly speed or line configuration.

• Packaging equipment maintenance.

• Storage, transport, or sample preparation.

• Product formulation or filling conditions, where relevant.

Compare failed samples with passing samples from the same lot and, where scientifically justified, other lots. Look for patterns by production time, component lot, line, or packaging configuration.

If failures cluster around a particular process change, escalate the investigation to the relevant manufacturing and quality teams.

 

7. Distinguish a Genuine Failure from a Test-System Problem

A structured decision sequence helps prevent premature conclusions.

First, determine whether the test was valid. If the instrument or control checks failed, address the system issue and assess the validity of affected results.

Second, verify the sample identity and configuration. Confirm that the package was tested using the correct method and fixture.

Third, review the failure signal. Compare the result with the method's validated behavior and available reference data.

Fourth, investigate the package. Use appropriate follow-up examination or a complementary method where justified.

Finally, document the conclusion. State the evidence supporting the identified cause, the impact assessment, and any corrective or preventive action.

An alternative method may provide useful information, but it should not be selected merely because it produces a passing result. The method must be appropriate for the suspected defect and the package system.

 

8. When Should a Batch-Level Investigation Begin?

A single unexpected failure does not automatically establish that an entire batch is defective, but it should be assessed under the manufacturer's quality system.

Consider the severity of the potential defect, the reliability of the original test, the number and distribution of failures, and the possible impact on product quality. Review whether other units share the same component lot, packaging line, process settings, or handling history.

Follow the established deviation, out-of-specification, and batch-disposition procedures. Decisions about additional sampling, repeat testing, product release, or rejection should be made by authorized quality personnel based on documented evidence.

 

9. How Can CCIT Failure Investigations Be Prevented from Recurring?

An investigation should result in more than a one-time correction. If the cause is identified, implement corrective action and assess whether the action is effective.

Possible improvements include fixture replacement, instrument maintenance, revised sample handling, operator retraining, recipe controls, or additional process monitoring. Update the risk assessment and test procedure when the evidence supports a change.

Trending failure rates and borderline results can reveal recurring problems. The review should include both instrument-related issues and manufacturing factors rather than assuming that all unexpected failures originate from the tester.

For pharmaceutical manufacturers that need method development or technical troubleshooting, Zholion’s CCIT services provide a relevant starting point for discussing package integrity testing and validation needs.

 

Frequently Asked Questions

What should be checked first when a CCIT test fails unexpectedly?

Preserve the original data, confirm the sample identity, review the approved test parameters, and check instrument and fixture status. The sequence should follow the quality procedure and avoid changing several variables at once.

Can a visual inspection overrule a failed CCIT result?

No. Visual inspection can identify obvious damage but cannot reliably exclude every leak path. A failed result should be investigated using the validated test method and appropriate supporting evidence.

Why are positive controls important in CCIT?

Positive controls help demonstrate that the test method can detect a defined defect under the specified conditions. Their design and acceptance criteria must be appropriate for the package and detection objective.

Should an unexpected failure always trigger a batch rejection?

Not automatically. Authorized quality personnel should assess the test validity, defect risk, investigation findings, and applicable batch procedures before deciding on disposition.

What information should be included in the investigation report?

Include the original result, sample details, equipment and fixture status, test parameters, control results, relevant manufacturing history, root-cause evidence, impact assessment, and documented corrective actions.

 

Investigate CCIT Failures with a Structured Approach

Reliable failure investigations protect product quality and help prevent unnecessary rework. Contact Zholion at marketing@zholion.co or visit www.zholionccit.com to discuss pharmaceutical leak detection equipment, positive controls, fixtures, or method-development support. Provide the package format, test method, failure pattern, and current test conditions to help define the next steps.